Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07507305Not ApplicableCompleted

Impact of Pharmaceutical Care Interventions on Health Outcomes of Patients With Type 2 Diabetes Mellitus in Yobe State University Teaching Hospital

Role: lead

NCT07154836Not ApplicableEnrolling By Invitation

Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria

Role: collaborator

NCT06179732Phase 3Completed

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

Role: collaborator

NCT05279105Unknown

Primary Health Care Delivery Models in Conflict Settings of Cameroon and Nigeria

Role: collaborator

NCT05254392Not ApplicableCompleted

Pharmacists' Interventions to Improve Blood Pressure in Chronic Kidney Disease

Role: lead

All 5 trials loaded